Testicular Tumors in Dogs — Management Guide

Comprehensive, practical guide to diagnosing and managing testicular tumors in dogs — Sertoli cell, seminoma, and interstitial (Leydig) cell tumors, including feminization, cryptorchid risk, treatment and follow-up.

Quick Overview

• What it is: Testicular tumors in dogs include three primary types — Sertoli cell tumors, seminomas, and interstitial (Leydig) cell tumors. They originate from different cell types in the testis and differ in behavior, paraneoplastic effects and metastatic potential.
• Who’s at risk: Older intact male dogs, and especially dogs with cryptorchid (retained) testicles. Cryptorchid testes have a substantially higher risk for Sertoli cell tumors and seminomas.
• Prognosis: Most testicular tumors are cured by castration (orchiectomy) when disease is confined to the testis. Prognosis worsens if there is metastasis. Sertoli cell tumors carry additional risk because they may secrete estrogen and cause feminization and bone marrow suppression.

Pathophysiology — explained simply

• Testicular anatomy briefly: Each testis contains germ cells (which may give rise to seminomas), Sertoli cells (supporting cells), and interstitial (Leydig) cells (produce testosterone). Tumors develop from one of these cell types.
• Seminomas: Arise from germ cells. They are often slow-growing and may be confined to the testicle, but some seminomas can metastasize to regional lymph nodes or lungs.
• Sertoli cell tumors: Originate from Sertoli cells. They can produce estrogen or estrogen-like effects causing feminization (symmetric alopecia, gynecomastia, attraction to male dogs) and may cause bone marrow suppression (leading to anemia and leukopenia).
• Interstitial (Leydig) cell tumors: Arise from testosterone-producing cells and are usually benign and nonfunctional. They rarely metastasize.

• Retained (cryptorchid) testes develop at a higher rate of neoplasia, particularly seminomas and Sertoli cell tumors. The abnormal environment (higher temperature, altered microenvironment) increases neoplastic transformation.

• Age: Testicular tumors are most common in middle-aged to older intact male dogs (typical presentation >6–8 years).
• Cryptorchid dogs: A retained testis carries a markedly increased risk for Sertoli cell tumors and seminomas (multiple veterinary oncology sources report several-fold higher risk in cryptorchid versus descended testes).
• Breed predisposition: No single breed is universally susceptible, but larger breeds and certain individual lines may show increased cases in some studies. Because testicular tumors are strongly age- and cryptorchid-associated, reproductive and breeding practices influence prevalence.

• Local signs:

• Systemic/paraneoplastic signs (classically with Sertoli cell tumors):

• Signs of metastasis (if present): weight loss, respiratory signs (if pulmonary spread), enlarged regional lymph nodes

• There is no single universally used histologic grade for testicular tumors in clinical practice; however, behavior is estimated based on tumor type (Sertoli and seminoma have higher malignant potential than interstitial cell tumors).
• Clinical staging focuses on extent: local (testis confined), regional spread (inguinal/mediastinal/abdominal lymph nodes), distant metastasis (lungs, sometimes liver).

Treatment options

Surgery — mainstay and often curative

• Orchiectomy (castration) is the primary treatment. If tumor is confined to the testis, removal cures the disease in most cases.

• If both testes are affected or a retained testis plus descended testis, bilateral orchiectomy is performed (with the consequence of permanent infertility and hormonal effects).
• Lymph node excision and thoracotomy are rarely indicated but may be considered if metastasectomy is appropriate.

• Supportive care for estrogen effects:

• Symptomatic therapy: analgesics (e.g., carprofen 2.2 mg/kg PO q12–24h) and appropriate wound care after surgery.

• Chemotherapy is not routine for most testicular tumors because many are benign or cured by castration. Chemo is considered when there is:

• Agents used (examples; protocols individualized by oncologist):

• Response and success rates:

• Radiation therapy

Alternative and adjunctive therapies

• No proven herbal or homeopathic cure for testicular neoplasia. Complementary measures (nutrition support, skin care for feminization-related dermatitis) may help quality of life but do not replace surgery or oncology care.

• Post-surgical follow-up:

• CBC monitoring:

• Fertility and behavior:

Prognosis and quality of life considerations

• Prognosis is generally excellent when tumors are confined to the testis and orchiectomy is performed:

• Quality of life: Most dogs recover well after surgery and have a normal quality of life. Severe estrogen-induced marrow suppression or widespread metastasis can reduce quality of life and requires aggressive care and honest discussion about goals of treatment.

• After surgery:

• Skin and coat care (if feminization caused alopecia or dermatitis):

• Behavior and management:

• Watch weight and activity; maintain regular follow-ups and imaging if advised by your clinician.

Seek immediate veterinary attention if your dog has any of the following:

• Sudden collapse, severe lethargy, pale or jaundiced gums (possible severe anemia)
• Uncontrolled bleeding or bruising (thrombocytopenia)
• High fever, severe infection, or signs of sepsis
• Trouble breathing, coughing persistently (possible pulmonary metastasis)
• Severe wound swelling, redness, discharge, or if the incision opens
• Any sudden swelling of the scrotum or abdomen

• Merck Veterinary Manual: general overview of testicular tumors and clinical features (primary reference for clinical approach).
• Withrow SJ, MacEwen EG. Small Animal Clinical Oncology (standard veterinary oncology textbook for tumor biology and treatment principles).
• ACVIM & Veterinary oncology literature: recommendations on staging, bone marrow support and chemotherapy use vary by case — specialist referral advised for metastatic disease.

Frequently Asked Questions